Abstract
The design of nanofibrous scaffold with dual-drugs have gained much interest for treatment of tissue defect after the post-surgery cancer site. Herein, we report the electrospinning of poly (3-hydroxybutyric acid) (P) and gelatin (G) nanofibrous scaffold with incorporation of 5-flurouracil (FU) (hydrophilic) and methotrexate (MT) (hydrophobic) as a dual-drug carrier to impart synergetic effect at post-surgery cancer site. The surface morphology of the nanofibrous scaffold were examined at different magnification. The in vitro release results demonstrated the sustained release over the period of 96 h. The in vitro cell cytotoxicity and fluorescent images of live and dead cells clearly exhibited strong antitumor activity against MCF-7 and MIA PaCa-2 cells. Moreover, both hydrophilic and hydrophobic drug showed a reasonable burst release from the scaffold. Thus, the nanofibrous scaffold could be a versatile system for the delivery of dual-drugs and as an implantable scaffold for post-surgery cancer treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.